Human adipose-derived stromal cells in a clinically applicable injectable alginate hydrogel: Phenotypic and immunomodulatory evaluation

Cytotherapy

Volumn 17, Issue 8, 2015, Pages 1104-1118

  Follin, Bjarke ^a   Juhl, Morten ^a   Cohen, Smadar ^b   Pedersen, Anders Elm ^c   Gad, Monika ^d   Kastrup, Jens ^a   Ekblond, Annette ^a  

^a University of Copenhagen   (Denmark)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d BIONEER A S   (Denmark)

Author keywords

Adipose tissue derived stromal cells (ASCs); Alginate; Immunogenicity; Immunosuppression; Injectable hydrogel; Licensing

Indexed keywords

ALGINIC ACID; ARGINYLGLYCYLASPARTIC ACID; BETA1 INTEGRIN; MESSENGER RNA; SCATTER FACTOR; THY 1 ANTIGEN; ARGINYL-GLYCYL-ASPARTIC ACID; GAMMA INTERFERON; GLUCURONIC ACID; HEXURONIC ACID; HGF PROTEIN, HUMAN; HYDROGEL; OLIGOPEPTIDE;

ADIPOSE DERIVED STEM CELL; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELL STRUCTURE; CELL VIABILITY; COCULTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEPATOCYTE GROWTH FACTOR GENE; HUMAN; HUMAN CELL; HYDROGEL; IMMUNOGENICITY; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MALE; MITOSIS INHIBITION; NORMAL HUMAN; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL CULTURE; ADIPOCYTE; ADIPOSE TISSUE; ADMINISTRATION AND DOSAGE; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; GENETICS; HISTOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADIPOCYTES; ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; ALGINATES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; GLUCURONIC ACID; HEPATOCYTE GROWTH FACTOR; HEXURONIC ACIDS; HUMANS; HYDROGEL; IMMUNOMODULATION; INTERFERON-GAMMA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; OLIGOPEPTIDES; RNA, MESSENGER; TISSUE EMBEDDING; YOUNG ADULT;

EID: 84937633122     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2015.04.008     Document Type: Article

References (46)

1. Friis T., Haack-Sørensen M., Mathiasen A.B., Ripa R.S., Kristoffersen U.S., Jørgensen E., et al. Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina. Scand Cardiovasc J 2011, 45:161-168.
2. Qayyum A.A., Haack-Sørensen M., Mathiasen A.B., Jørgensen E., Ekblond A., Kastrup J. Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design. Regen Med 2012, 7:421-428.
3. Hare J.M., Fishman J.E., Gerstenblith G., DiFede Velazquez D.L., Zambrano J.P., Suncion V.Y., et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 2012, 308:2369-2379.
4. Povsic T.J., Junge C., Nada A., Schatz R.A., Harrington R.A., Davidson C.J., et al. A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study. Am Heart J 2013, 165:854-861.e2.
5. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98.
6. Malliaras K., Marbán E. Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull 2011, 98:161-185.
7. Caplan A.I., Correa D. The MSC: an injury drugstore. Cell Stem Cell 2011, 9:11-15.
8. Mathiasen A.B., Haack-Sørensen M., Jørgensen E., Kastrup J. Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina-final 3-year follow-up. Int J Cardiol 2013, 170:246-251.
9. Tossios P., Krausgrill B., Schmidt M., Fischer T., Halbach M., Fries J.W.U., et al. Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction. Eur Heart J 2008, 29:1911-1921.
10. Kraitchman D.L., Heldman A.W., Atalar E., Amado L.C., Martin B.J., Pittenger M.F., et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003, 107:2290-2293.
11. Terrovitis J.V., Smith R.R., Marbán E. Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 2010, 106:479-494.
12. Mathieu E., Lamirault G., Toquet C., Lhommet P., Rederstorff E., Sourice S., et al. Intramyocardial delivery of mesenchymal stem cell-seeded hydrogel preserves cardiac function and attenuates ventricular remodeling after myocardial infarction. PLoS One 2012, 7:e51991.
13. Levit R.D., Landázuri N., Phelps E.A., Brown M.E., García A.J., Davis M.E., et al. Cellular encapsulation enhances cardiac repair. J Am Heart Assoc 2013, 2:e000367.
14. Tongers J., Webber M.J., Vaughan E.E., Sleep E., Renault M.-A., Roncalli J.G., et al. Enhanced potency of cell-based therapy for ischemic tissue repair using an injectable bioactive epitope presenting nanofiber support matrix. J Mol Cell Cardiol 2014, 74C:231-239.
15. Landa N., Miller L., Feinberg M.S., Holbova R., Shachar M., Freeman I., et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008, 117:1388-1396.
16. Leor J., Tuvia S., Guetta V., Manczur F., Castel D., Willenz U., et al. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J Am Coll Cardiol 2009, 54:1014-1023.
17. Ungerleider J.L., Christman K.L. Concise Review: injectable biomaterials for the treatment of myocardial infarction and peripheral artery disease: Translational Challenges and Progress. Stem Cells Transl Med 2014, 3:1090-1099.
18. Duggal S., Frønsdal K.B., Szöke K., Shahdadfar A., Melvik J.E., Brinchmann J.E. Phenotype and gene expression of human mesenchymal stem cells in alginate scaffolds. Tissue Eng Part A 2009, 15:1763-1773.
19. Landázuri N., Levit R.D., Joseph G., Ortega-Legaspi J.M., Flores C.A., Weiss D., et al. Alginate microencapsulation of human mesenchymal stem cells as a strategy to enhance paracrine-mediated vascular recovery after hindlimb ischaemia. J Tissue Eng Regen Med 2012, term.1680.
20. Al-Shamkhani A., Duncan R. Radioiodination of Alginate via Covalently-Bound Tyrosinamide Allows Monitoring of its Fate In Vivo. J Bioact Compat Polym 1995, 10:4-13.
21. Kalantari S., Rutishauser D., Samavat S., Nafar M., Mahmudieh L., Rezaei-Tavirani M., et al. Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography. PLoS One 2013, 8:e80830.
22. Hamano Y., Grunkemeyer J.A., Sudhakar A., Zeisberg M., Cosgrove D., Morello R., et al. Determinants of vascular permeability in the kidney glomerulus. J Biol Chem 2002, 277:31154-31162.
23. Follin B., Tratwal J., Haack-Sørensen M., Elberg J.J., Kastrup J., Ekblond A. Identical effects of VEGF and serum-deprivation on phenotype and function of adipose-derived stromal cells from healthy donors and patients with ischemic heart disease. J Transl Med 2013, 11:219.
24. Tsur-Gang O., Ruvinov E., Landa N., Holbova R., Feinberg M.S., Leor J., et al. The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials 2009, 30:189-195.
25. Tratwal J., Follin B., Ekblond A., Kastrup J., Haack-Sørensen M. Identification of a common reference gene pair for qPCR in human mesenchymal stromal cells from different tissue sources treated with VEGF. BMC Mol Biol 2014, 15:11.
26. Jensen S.S., Gad M. Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity. J Inflamm (Lond) 2010, 7:37.
27. Re'em T., Tsur-Gang O., Cohen S. The effect of immobilized RGD peptide in macroporous alginate scaffolds on TGFbeta1-induced chondrogenesis of human mesenchymal stem cells. Biomaterials 2010, 31:6746-6755.
28. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
29. Bourin P., Bunnell B.A., Casteilla L., Dominici M., Katz A.J., March K.L., et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International So. Cytotherapy 2013, 15:641-648.
30. Krampera M., Galipeau J., Shi Y., Tarte K., Sensebe L. Immunological characterization of multipotent mesenchymal stromal cells-the International Society for Cellular Therapy (ISCT) working proposal. Cytotherapy 2013, 15:1054-1061.
31. Ruvinov E., Cohen S., Sapir Y. Cardiac tissue engineering: principles, materials, and applications synthesis lectures on tissue engineering. Synth Lect Tissue Engineer 2012, 4:1-200.
32. Chandler E.M., Berglund C.M., Lee J.S., Polacheck W.J., Gleghorn J.P., Kirby B.J., et al. Stiffness of photocrosslinked RGD-alginate gels regulates adipose progenitor cell behavior. Biotechnol Bioeng 2011, 108:1683-1692.
33. Karlsen T.A., Mirtaheri P., Shahdadfar A., Fløisand Y., Brinchmann J.E. Effect of three-dimensional culture and incubator gas concentration on phenotype and differentiation capability of human mesenchymal stem cells. J Cell Biochem 2011, 112:684-693.
34. Chang C.P., Chio C.C., Cheong C.U., Chao C.M., Cheng B.C., Lin M.T. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. Clin Sci (Lond) 2013, 124:165-176.
35. Calvani M., Rapisarda A., Uranchimeg B., Shoemaker R.H., Melillo G. Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 2006, 107:2705-2712.
36. Abdeen A.A., Weiss J.B., Lee J., Kilian K.A. Matrix composition and mechanics direct proangiogenic signaling from mesenchymal stem cells. Tissue Eng Part A 2014, 20:2737-2745.
37. Villaschi S., Nicosia R.F. Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury. Am J Pathol 1993, 143:181-190.
38. Deuse T., Peter C., Fedak P.W.M., Doyle T., Reichenspurner H., Zimmermann W.H., et al. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation 2009, 120:S247-S254.
39. Park J., Babensee J.E. Differential functional effects of biomaterials on dendritic cell maturation. Acta Biomater 2012, 8:3606-3617.
40. Babensee J.E. Interaction of dendritic cells with biomaterials. Semin Immunol 2008, 20:101-108.
41. Liu W., Liu J., Wu J., Zhang L., Liu F., Yin L., et al. Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway. PLoS One 2013, 8:e55487.
42. Peng W., Gao T., Yang Z.L., Zhang S.C., Ren M.L., Wang Z.G., et al. Adipose-derived stem cells induced dendritic cells undergo tolerance and inhibit Th1 polarization. Cell Immunol 2012, 278:152-157.
43. Larocca R.A., Moraes-Vieira P.M., Bassi E.J., Semedo P., de Almeida D.C., da Silva M.B., et al. Adipose tissue-derived mesenchymal stem cells increase skin allograft survival and inhibit Th-17 immune response. PLoS One 2013, 8:e76396.
44. Van Den Akker F., De Jager S.C.A., Sluijter J.P.G. Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors. Mediators Inflamm 2013, 2013.
45. Puissant B., Barreau C., Bourin P., Clavel C., Corre J., Bousquet C., et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005, 129:118-129.
46. Shachar M., Tsur-Gang O., Dvir T., Leor J., Cohen S. The effect of immobilized RGD peptide in alginate scaffolds on cardiac tissue engineering. Acta Biomater 2011, 7:152-162.